LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $61 | $61 | $61 |
| - Cash | $23 | $15 | $21 |
| + Debt | $4 | $0 | $24 |
| Enterprise Value | $42 | $46 | $64 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$63 | -$1 | -$12 |
| % Margin | – | – | – |
| Net Income | -$63 | -$6 | -$14 |
| % Margin | – | – | – |
| EPS Diluted | -17.83 | -1.77 | -4.05 |
| % Growth | -907.3% | 56.3% | – |
| Operating Cash Flow | -$53 | -$12 | -$3 |
| Capital Expenditures | -$1 | -$0 | $0 |
| Free Cash Flow | -$54 | -$12 | -$3 |